Tolecine
Latest Information Update: 16 Jul 2016
At a glance
- Originator Kent State University
- Developer IC-MedTech; Kent State University; Summa Health System
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Sexually transmitted infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Sexually transmitted infections in USA
- 01 Jan 2011 Preclinical trials in Cancer in USA (unspecified route)